Home / Stocks / MRSH

Marsh & McLennan Companies (MRSH, Insurance Brokers) Stock Valuation & Fair Value Fairly valued

Marsh & McLennan Companies (MRSH, Insurance Brokers) trades at a blended P/E of 17.7 — about 12% below its historical normal valuation — with a forward growth estimate of 8.5% and a PEG of 2.08. Analysts' one-year estimates have been hit 91% of the time.

Blended P/E
17.7
Normal P/E
20.2
PEG
2.08
Fwd growth
8.5%
Div yield
2.2%

Valuation flags

Verdict history

tickerseer's rating has been fairly valued since 2026-06-03.

2026-06-03P/E 15.9-21%Fairly valued
2026-06-10P/E 16.5-18%Fairly valued
2026-06-14P/E 16.5-18%Fairly valued
2026-06-16P/E 16.5-18%Fairly valued
2026-06-21P/E 16.5-18%Fairly valued
2026-07-02P/E 17.1-15%Fairly valued
2026-07-06P/E 17.7-12%Fairly valued
2026-07-09P/E 17.7-12%Fairly valued
2026-07-12P/E 17.7-12%Fairly valued
2026-07-13P/E 17.7-12%Fairly valued
2026-07-14P/E 17.7-12%Fairly valued ← now

Frequently asked questions

Is Marsh & McLennan Companies stock overvalued?

At a blended P/E of 17.7 versus its historical normal P/E of 20.2, Marsh & McLennan Companies trades about 12% below its typical valuation, with a PEG of 2.08 on 8.5% forward growth — tickerseer currently rates it fairly valued.

What is Marsh & McLennan Companies's fair value and PEG?

Marsh & McLennan Companies trades at a blended P/E of 17.7 against a historical normal P/E of 20.2, a PEG of 2.08, and a forward growth estimate of 8.5%.

Has tickerseer's rating of Marsh & McLennan Companies changed?

tickerseer's rating has been fairly valued since 2026-06-03.

Industry: Insurance Brokers. Create a free account to unlock the full analysis — the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.